|
Robert Tools, who
won the hearts of millions of Americans after becoming the recipient
of the world's first totally implantable artificial heart, died
Friday at Jewish Hospital in Louisville from uncontrolled abdominal
bleeding and multiple organ failure.
Tools' death, and the
death of a man receiving the 6th artificial heart during surgery
earlier in the week in Houston, put a damper on the almost unbridled
optimism that has surrounded the clinical trials of the AbioCor
mechanical heart for the past five months.
Patients accepted into
the AbioCor trial must suffer from otherwise untreatable bi-ventricular
heart failure, be too ill to be eligible for human heart transplantation,
and have a high probability of dying within 30 days.
When Tools received
the implant July 2, doctors said they would be happy if he lived
with the new heart for 60 days.
But Tools' recovery
exceeded all expectations. Several months after the implant, he
was making frequent trips outside the hospital, including lunches
at area restaurants, fishing with his physicians and an evening
at a comedy club.
Tools' hopes of being discharged
from the hospital were dashed, however, when he suffered a serious
stroke Nov. 11. Doctors said the bleeding and subsequent organ
failure that led to his death were not related to the stroke,
nor to complications or a malfunction of the AbioCor device.
"We will miss
Bob's laugh, his sense of humor and his fighting spirit,'' said
Dr. Rob D. Dowling, one of his surgeons. "Mr. Tools and his
family members are heroes. Their willingness to be the first to
participate in the AbioCor clinical trial could potentially pave
the way for a revolutionary treatment option for advanced heart
disease."
Only two days earlier,
an unidentified man suffering from chronic heart failure became
the first patient of the AbioCor trials to die during efforts
to implant a mechanical heart at St. Luke's Episcopal Hospital
in Houston. The surgical team spent 20 hours trying to control
bleeding during surgery in the man.
Four other patients
who have undergone AbioCor implants -- one in Louisville, one
in Houston, one in Los Angeles and one in Philadelphia -- are
still alive.
"All
four right now are in varying stages of recovery," said Ed
Berger, Abiomed vice president for strategic policy and planning.
"Nobody has gone home, and we don't have the dramatic positive
story that eventually we are going to see, but it's very encouraging
to us so far."
Abiomed has
been granted permission to perform as many as 15 implants, and
the company plans to continue with the trial despite Tools's death.
William Schroeder
of Jasper, Ind., holds the survival record among artificial-heart
recipients, living 620 days with a Jarvik-7 before dying in 1986.
Other
sources: Abiomed, Jewish Hospital
|